ZYUS Life Sciences Corporation
ZLSCF
$0.59
-$0.0501-7.83%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -75.53% | -70.17% | -96.20% | -95.59% | 176.70% |
| Total Receivables | -62.50% | -46.42% | -22.31% | 171.18% | 253.58% |
| Inventory | -75.60% | -71.68% | -50.42% | -51.27% | -46.68% |
| Prepaid Expenses | -52.56% | -50.88% | -61.35% | -68.54% | -57.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -71.37% | -67.13% | -77.65% | -82.25% | -9.66% |
|
|
|||||
| Total Current Assets | -71.37% | -67.13% | -77.65% | -82.25% | -9.66% |
| Net Property, Plant & Equipment | -26.31% | -26.28% | -19.91% | -22.09% | -18.32% |
| Long-term Investments | -- | -- | 0.13% | -3.25% | -0.08% |
| Goodwill | -- | -- | 0.13% | -3.25% | -0.08% |
| Total Other Intangibles | -- | -100.00% | -64.43% | -64.41% | -64.20% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.79% | -8.25% | -2.43% | -5.69% | -2.60% |
| Total Assets | -69.21% | -67.65% | -52.63% | -56.99% | -40.74% |
|
|
|||||
| Total Accounts Payable | 13.89% | 19.79% | 46.45% | -23.09% | -55.27% |
| Total Accrued Expenses | -- | -4.89% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 68.87% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.07% | 32.26% | -36.90% | -14.53% | 1,918.40% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.05% | 20.46% | 4.10% | -18.44% | -15.73% |
|
|
|||||
| Total Current Liabilities | -9.05% | 20.46% | 4.10% | -18.44% | -15.73% |
| Long-Term Debt | 589.66% | -46.55% | -39.38% | -38.49% | -97.80% |
| Short-term Debt | -- | -- | -- | 68.87% | -- |
| Capital Leases | -20.96% | -20.53% | -11.13% | -13.46% | -8.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -74.82% | -74.66% | -83.68% |
| Total Liabilities | 3.59% | -0.76% | -23.83% | -33.63% | -71.82% |
|
|
|||||
| Common Stock & APIC | -1.54% | -4.52% | 2.91% | -4.24% | 62.12% |
| Retained Earnings | -16.81% | -13.92% | -31.77% | -25.62% | -40.21% |
| Treasury Stock & Other | -12.94% | -34.17% | 7.60% | 4.41% | 0.49% |
| Total Common Equity | -135.05% | -121.22% | -68.10% | -70.52% | 21,924.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -135.05% | -121.22% | -68.10% | -70.52% | 21,924.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -135.05% | -121.22% | -68.10% | -70.52% | 21,924.07% |
|
|
|||||